Advertisement
Review Article|Articles in Press

Surgical Approach to Esophagectomy Post CheckMate 577

Do Lymph Nodes Matter if Everyone Gets Adjuvant Immunotherapy?
Published:February 26, 2023DOI:https://doi.org/10.1016/j.thorsurg.2023.01.002
Surgical Approach to Esophagectomy Post CheckMate 577
Previous ArticleStereotactic Body Radiation Therapy Versus Ablation Versus Surgery for Early-Stage Lung Cancer in High-Risk Patients

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Thoracic Surgery Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      References

        • van Hagen P.
        • Hulshof M.C.C.M.
        • van Lanschot JJB
        • et al.
        Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer.
        N Engl J Med. 2012; 366: 2074-2084
        View in Article
        • Blum Murphy M.
        • Xiao L.
        • Patel V.R.
        • et al.
        Pathological complete response in patients with esophageal cancer after the trimodality approach: The association with baseline variables and survival—The University of Texas MD Anderson Cancer Center experience.
        Cancer. 2017; 123: 4106-4113
        View in Article
        • Eyck B.M.
        • van Lanschot JJB
        • Hulshof M.C.C.M.
        • et al.
        Ten-Year Outcome of Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal Cancer: The Randomized Controlled CROSS Trial.
        J Clin Oncol. 2021; 39: 1995-2004
        View in Article
        • Kato K.
        • Cho B.C.
        • Takahashi M.
        • et al.
        Nivolumab versus chemotherapy in patients with advanced oesophageal squamous cell carcinoma refractory or intolerant to previous chemotherapy (ATTRACTION-3): a multicentre, randomised, open-label, phase 3 trial.
        Lancet Oncol. 2019; 20: 1506-1517
        View in Article
        • Doki Y.
        • Ajani J.A.
        • Kato K.
        • et al.
        Nivolumab Combination Therapy in Advanced Esophageal Squamous-Cell Carcinoma.
        N Engl J Med. 2022; 386: 449-462
        View in Article
        • Kelly R.J.
        • Ajani J.A.
        • Kuzdzal J.
        • et al.
        Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer.
        N Engl J Med. 2021; 384: 1191-1203
        View in Article
        • Sihag S.
        • Ku G.Y.
        • Tan K.S.
        • et al.
        Safety and feasibility of esophagectomy following combined immunotherapy and chemoradiotherapy for esophageal cancer.
        J Thorac Cardiovasc Surg. 2021; 161: 836-843.e1
        View in Article
        • Wang Y.
        • Zhu L.
        • Xia W.
        • et al.
        Anatomy of lymphatic drainage of the esophagus and lymph node metastasis of thoracic esophageal cancer.
        Cancer Manag Res. 2018; 10: 6295
        View in Article
        • Li B.
        • Zhang Y.
        • Miao L.
        • et al.
        Esophagectomy With Three-Field Versus Two-Field Lymphadenectomy for Middle and Lower Thoracic Esophageal Cancer: Long-Term Outcomes of a Randomized Clinical Trial.
        J Thorac Oncol. 2021; 16: 310-317
        View in Article
        • Stein H.J.
        • Feith M.
        • Bruecher B.L.D.M.
        • et al.
        Early Esophageal Cancer: Pattern of Lymphatic Spread and Prognostic Factors for Long-Term Survival After Surgical Resection.
        Ann Surg. 2005; 242: 566
        View in Article
        • Buskens C.J.
        • Westerterp M.
        • Lagarde S.M.
        • et al.
        Prediction of appropriateness of local endoscopic treatment for high-grade dysplasia and early adenocarcinoma by EUS and histopathologic features.
        Gastrointest Endosc. 2004; 60: 703-710
        View in Article
        • Rice T.W.
        • Blackstone E.H.
        • Goldblum J.R.
        • et al.
        Superficial adenocarcinoma of the esophagus.
        J Thorac Cardiovasc Surg. 2001; 122: 1077-1090
        View in Article
        • Cho J.W.
        • Choi S.C.
        • Jang J.Y.
        • et al.
        Lymph Node Metastases in Esophageal Carcinoma: An Endoscopist’s View.
        Clin Endosc. 2014; 47: 523
        View in Article
        • Kingma B.F.
        • Ruurda J.P.
        • van Hillegersberg R.
        An Editorial on Lymphadenectomy in Esophagectomy for Cancer.
        Ann Surg Oncol. 2022; 29: 4676-4678
        View in Article
        • Nafteux P.
        • Depypere L.
        • Veer H Van
        • et al.
        Principles of esophageal cancer surgery, including surgical approaches and optimal node dissection (2- vs . 3-field).
        Ann Cardiothorac Surg. 2017; 6: 15258
        View in Article
        • Tachibana M.
        • Kinugasa S.
        • Yoshimura H.
        • et al.
        Extended Esophagectomy With 3-Field Lymph Node Dissection for Esophageal Cancer.
        Arch Surg. 2003; 138: 1383-1389
        View in Article
        • Chen D.
        • Mao Y.
        • Xue Y.
        • et al.
        Does the lymph node yield affect survival in patients with esophageal cancer receiving neoadjuvant therapy plus esophagectomy? A systematic review and updated meta-analysis.
        EClinicalMedicine. 2020; 25: 100431
        View in Article
        • McMillian N.
        • Lenora Pluchino M.A.
        • Ajani J.A.
        • et al.
        NCCN Guidelines Version 4.2022 Esophageal and Esophagogastric Junction Cancers.
        (Available at:)
        https://www.nccn.org/home/
        Date: 2022
        (Accessed September 13, 2022)
        View in Article
        • Domene C.E.
        • Volpe P.
        Do robotic arms retrieve more lymph nodes during an esophagectomy?.
        Ann Esophagus. 2020; 3https://doi.org/10.21037/AOE.2020.02.03
        View in Article
        • Wang X.
        • Hu Y.
        • Wu X.
        • et al.
        Near-infrared fluorescence imaging-guided lymphatic mapping in thoracic esophageal cancer surgery.
        Surg Endosc. 2022; 36: 3994-4003
        View in Article
        • Hachey K.J.
        • Gilmore D.M.
        • Armstrong K.W.
        • et al.
        Safety and feasibility of near-infrared image-guided lymphatic mapping of regional lymph nodes in esophageal cancer.
        J Thorac Cardiovasc Surg. 2016; 152: 546-554
        View in Article
        • Jimenez-Lillo J.
        • Villegas-Tovar E.
        • Momblan-Garcia D.
        • et al.
        Performance of Indocyanine-Green Imaging for Sentinel Lymph Node Mapping and Lymph Node Metastasis in Esophageal Cancer: Systematic Review and Meta-Analysis.
        Ann Surg Oncol. 2021; 28: 4869-4877
        View in Article
        • Sihag S.
        • Kosinski A.S.
        • Gaissert H.A.
        • et al.
        Minimally Invasive Versus Open Esophagectomy for Esophageal Cancer: A Comparison of Early Surgical Outcomes from the Society of Thoracic Surgeons National Database.
        Ann Thorac Surg. 2016; 101: 1281-1289
        View in Article

      Article info

      Publication history

      Published online: February 26, 2023

      Publication stage

      In Press Corrected Proof

      Identification

      DOI: https://doi.org/10.1016/j.thorsurg.2023.01.002

      Copyright

      © 2023 Elsevier Inc. All rights reserved.

      ScienceDirect

      Access this article on ScienceDirect
      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties. The content on this site is intended for healthcare professionals.


      RELX